Current controversies in pediatric radiation oncology

Area of Science:

• Oncology
• Radiation Oncology
• Pediatric Oncology

Background:

• Radiotherapy is a standard treatment for Ewing sarcoma and pediatric soft-tissue sarcomas.
• The role of radiotherapy in Ewing sarcoma management is debated, with survival rates potentially similar to surgery for primary lesions.

Purpose of the Study:

• To evaluate the efficacy of radiotherapy in managing pediatric soft-tissue sarcomas.
• To determine optimal radiotherapy strategies for Ewing sarcoma and nonrhabdomyosarcoma soft-tissue sarcomas based on surgical margins and chemotherapy response.

Main Methods:

• Review of treatment outcomes for patients with Ewing sarcoma and pediatric soft-tissue sarcomas.
• Analysis of survival rates and local control in relation to radiotherapy and surgical interventions.
• Assessment of the impact of surgical margin status and chemotherapy on radiotherapy effectiveness.

Main Results:

• In Ewing sarcoma, radiotherapy for primary lesions shows comparable survival rates to surgery, though interpretation requires caution.
• Postoperative irradiation is recommended for Ewing sarcoma and nonrhabdomyosarcoma soft-tissue sarcomas when surgical margins are narrow (< wide).
• For nonrhabdomyosarcoma soft-tissue sarcomas, a dose of 54 Gy at 1.8 Gy per day postoperatively ensures excellent local control.

Conclusions:

• Radiotherapy is a viable option for primary Ewing sarcoma treatment, potentially matching surgical outcomes.
• Adjuvant radiotherapy is essential for achieving local control in soft-tissue sarcomas with positive or close surgical margins.
• Specific radiotherapy dosing regimens are effective in managing pediatric soft-tissue sarcomas, particularly when margins are compromised.